BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1586998)

  • 1. Comparison of Ki-ras gene mutation among simultaneously occurring multiple urethan-induced lung tumors in individual mice.
    Ohmori H; Abe T; Hirano H; Murakami T; Katoh T; Gotoh S; Kido M; Kuroiwa A; Nomura T; Higashi K
    Carcinogenesis; 1992 May; 13(5):851-5. PubMed ID: 1586998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
    Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
    Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethan-induced and butylated hydroxytoluene-promoted lung tumors of strain A/J and SWR mice.
    Wang X; Witschi H
    Cancer Lett; 1995 May; 91(1):33-9. PubMed ID: 7750092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice.
    Cazorla M; Hernández L; Fernández PL; Fabra A; Peinado MA; Dasenbrock C; Tillmann T; Kamino K; Campo E; Kohler M; Morawieltz G; Cardesa A; Tomatis L; Mohr U
    Mol Carcinog; 1998 Apr; 21(4):251-60. PubMed ID: 9585255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas.
    Nuzum EO; Malkinson AM; Beer DG
    Mol Carcinog; 1990; 3(5):287-95. PubMed ID: 2244961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.
    McKenna IM; Ramakrishna G; Diwan BA; Kang Y; Shiao YH; Wakefield LM; Powell DA; Anderson LM; Jakowlew SB
    Toxicol Lett; 2001 Sep; 123(2-3):151-8. PubMed ID: 11641043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search for Ki-ras codon 61 mutations in lung adenomas induced in neonatal BALB/c mice with 5-bromodesoxyuridine injection followed by urethane treatment].
    Imianitov EN; Togo AV; Anisimov VN
    Vopr Onkol; 1999; 45(5):542-5. PubMed ID: 10629714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.
    Lin L; Festing MF; Devereux TR; Crist KA; Christiansen SC; Wang Y; Yang A; Svenson K; Paigen B; Malkinson AM; You M
    Exp Lung Res; 1998; 24(4):481-97. PubMed ID: 9659579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
    Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
    Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse.
    Devereux TR; Anderson MW; Belinsky SA
    Carcinogenesis; 1991 Feb; 12(2):299-303. PubMed ID: 1995195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
    Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
    Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
    Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
    Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J x BALB/cJ) mice.
    Massey TE; Devereux TR; Maronpot RR; Foley JF; Anderson MW
    Carcinogenesis; 1995 May; 16(5):1065-9. PubMed ID: 7767966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse.
    Herzog CR; Schut HA; Maronpot RR; You M
    Mol Carcinog; 1993; 8(3):202-7. PubMed ID: 8216739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.
    You M; Candrian U; Maronpot RR; Stoner GD; Anderson MW
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3070-4. PubMed ID: 2654935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Ki-67 antigen expression and K-ras mutation in lung tumours induced by urethane in mice.
    Koohdani F; Sasani F; Mohammad K; Mehdipour P
    Singapore Med J; 2009 Jul; 50(7):729-33. PubMed ID: 19644632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene.
    Wessner LL; Fan M; Schaeffer DO; McEntee MF; Miller MS
    Carcinogenesis; 1996 Jul; 17(7):1519-26. PubMed ID: 8706258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.